Search research articles
Contact Us
Filters
Showing results (41-50 of 73) with videos related to
Page
of 8
Sort By:
Cancers
|
September 27, 2025
First-in-Human Study of MDG1011, a TCR-T Therapy Directed Against HLA-A*02:01-Restricted PRAME Antigen for High-Risk Myeloid and Lymphoid Neoplasms
Simone Thomas, Martin Wermke, Vladan Vučinić, et al.
Plos One
|
June 22, 2016
A Randomized, Double-Blind, Placebo-Controlled Phase II Trial Investigating the Safety and Immunogenicity of Modified Vaccinia Ankara Smallpox Vaccine (MVA-BN®) in 56-80-Year-Old Subjects
Richard N Greenberg, Christine M Hay, Jack T Stapleton, et al.
The Journal of Clinical Investigation
|
September 20, 2016
Axial tubule junctions control rapid calcium signaling in atria
Sören Brandenburg, Tobias Kohl, George S B Williams, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
March 17, 2019
Changes in Immunosuppressive Treatment of Chronic Graft-versus-Host Disease: Comparison of 2 Surveys within Allogeneic Hematopoietic Stem Cell Transplant Centers in Germany, Austria, and Switzerland
Daniel Wolff, Inken Hilgendorf, Eva Wagner-Drouet, et al.
Open Forum Infectious Diseases
|
September 18, 2015
Safety and Immunogenicity of Modified Vaccinia Ankara-Bavarian Nordic Smallpox Vaccine in Vaccinia-Naive and Experienced Human Immunodeficiency Virus-Infected Individuals: An Open-Label, Controlled Clinical Phase II Trial
Edgar Turner Overton, Jack Stapleton, Ian Frank, et al.
Diagnostics (Basel, Switzerland)
|
March 6, 2021
Comparison of Cytomegalovirus-Specific Immune Cell Response to Proteins versus Peptides Using an IFN-γ ELISpot Assay after Hematopoietic Stem Cell Transplantation
Eva Wagner-Drouet, Daniel Teschner, Christine Wolschke, et al.
Transplantation and Cellular Therapy
|
April 13, 2026
Survival trends in young adults with acute leukaemia after AHSCT in Germany: comparisons with younger and older patients
Jochen J Frietsch, Sarah Flossdorf, Ashrafossadat Ahmadian, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 15, 2025
Ruxolitinib Versus Best Available Therapy in Patients With Steroid-Refractory Acute Graft-Versus-Host Disease: Final Analysis From the Randomized Phase III REACH2 Trial
Mohamad Mohty, Gerard Socié, Jeff Szer, et al.
Circulation Research
|
June 23, 2012
Stimulated emission depletion live-cell super-resolution imaging shows proliferative remodeling of T-tubule membrane structures after myocardial infarction
Eva Wagner, Marcel A Lauterbach, Tobias Kohl, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 22, 2019
A Phase I Dose-Escalation Trial of BN-CV301, a Recombinant Poxviral Vaccine Targeting MUC1 and CEA with Costimulatory Molecules
Margaret E Gatti-Mays, Julius Strauss, Renee N Donahue, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 73) with videos related to
Sort By:
Page
of 8
Cancers
|
September 27, 2025
First-in-Human Study of MDG1011, a TCR-T Therapy Directed Against HLA-A*02:01-Restricted PRAME Antigen for High-Risk Myeloid and Lymphoid Neoplasms
Simone Thomas, Martin Wermke, Vladan Vučinić, et al.
Plos One
|
June 22, 2016
A Randomized, Double-Blind, Placebo-Controlled Phase II Trial Investigating the Safety and Immunogenicity of Modified Vaccinia Ankara Smallpox Vaccine (MVA-BN®) in 56-80-Year-Old Subjects
Richard N Greenberg, Christine M Hay, Jack T Stapleton, et al.
The Journal of Clinical Investigation
|
September 20, 2016
Axial tubule junctions control rapid calcium signaling in atria
Sören Brandenburg, Tobias Kohl, George S B Williams, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
March 17, 2019
Changes in Immunosuppressive Treatment of Chronic Graft-versus-Host Disease: Comparison of 2 Surveys within Allogeneic Hematopoietic Stem Cell Transplant Centers in Germany, Austria, and Switzerland
Daniel Wolff, Inken Hilgendorf, Eva Wagner-Drouet, et al.
Open Forum Infectious Diseases
|
September 18, 2015
Safety and Immunogenicity of Modified Vaccinia Ankara-Bavarian Nordic Smallpox Vaccine in Vaccinia-Naive and Experienced Human Immunodeficiency Virus-Infected Individuals: An Open-Label, Controlled Clinical Phase II Trial
Edgar Turner Overton, Jack Stapleton, Ian Frank, et al.
Diagnostics (Basel, Switzerland)
|
March 6, 2021
Comparison of Cytomegalovirus-Specific Immune Cell Response to Proteins versus Peptides Using an IFN-γ ELISpot Assay after Hematopoietic Stem Cell Transplantation
Eva Wagner-Drouet, Daniel Teschner, Christine Wolschke, et al.
Transplantation and Cellular Therapy
|
April 13, 2026
Survival trends in young adults with acute leukaemia after AHSCT in Germany: comparisons with younger and older patients
Jochen J Frietsch, Sarah Flossdorf, Ashrafossadat Ahmadian, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 15, 2025
Ruxolitinib Versus Best Available Therapy in Patients With Steroid-Refractory Acute Graft-Versus-Host Disease: Final Analysis From the Randomized Phase III REACH2 Trial
Mohamad Mohty, Gerard Socié, Jeff Szer, et al.
Circulation Research
|
June 23, 2012
Stimulated emission depletion live-cell super-resolution imaging shows proliferative remodeling of T-tubule membrane structures after myocardial infarction
Eva Wagner, Marcel A Lauterbach, Tobias Kohl, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 22, 2019
A Phase I Dose-Escalation Trial of BN-CV301, a Recombinant Poxviral Vaccine Targeting MUC1 and CEA with Costimulatory Molecules
Margaret E Gatti-Mays, Julius Strauss, Renee N Donahue, et al.
Page
of 8